Search

Your search keyword '"Hinrichsen H."' showing total 125 results

Search Constraints

Start Over You searched for: Author "Hinrichsen H." Remove constraint Author: "Hinrichsen H." Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
125 results on '"Hinrichsen H."'

Search Results

1. Renormalized equations of motions for scalars and fermions in the 2PI formalism

2. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients

4. Renormalized equations of motion for scalars and fermions in the 2PI formalism.

8. Reproduction of Baltic cod, Gadus morhua (Actinopterygii: Gadiformes: Gadidae), in the Gotland Basin: Causes of annual variability

9. Real‐world experience with the all‐oral, interferon‐free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry

14. Response to discontinuation of nucleos(t)ide analogue treatment in HBeAg-negative chronic hepatitis B: results from the Stop-NUC trial

16. Barrieren der Hepatitis-C-Virus (HCV) Elimination in Deutschland: warum erhalten diagnostizierte Patienten keine Therapie?

18. High effectiveness of elbasvir/grazoprevir (EBR/GZR) treatment in patients with HCV genotype 1a (GT1a) infection in German real-world: results from the German Hepatitis C Registry (DHC-R)

19. Real World Experience of Prescribing Tenofovir Alafenamide for Chronic Hepatitis B Patients in Germany

21. High real-world efficacy of elbasvir/grazoprevir (EBR/GZR) in genotype 1 (GT1) infected patients with and without liver cirrhosis: results from the German Hepatitis C Registry (DHC-R)

22. Whole metabolome profiling identifies the combination of an eicosanoid, a bile acid and an androgen as a highly accurate marker of liver fibrosis in patients with non-alcoholic fatty liver disease

24. Biophysical modeling of survival and dispersal of Central and Eastern Baltic Sea flounder (Platichthys flesus) larvae

25. Ocean current connectivity propelling the secondary spread of a marine invasive comb jelly across western Eurasia

27. Utilization of elbasvir/grazoprevir (EBR/GZR) and adoption of resistance associated substitutions (RAS) testing in real-world treatment of HCV genotype 1 (GT1) infection: results from the German Hepatitis C Registry (DHC-R)

28. Prävalenz von HCV NS5A Resistenzen und Therapieansprechen bei DAA-naiven Patienten mit einer chronischen Genotyp (GT) 1a Hepatitis C Virusinfektion

29. Diagnostik der Leberfibrose bei nicht-alkoholischer Fettlebererkrankung mittels Composite Score aus einem Eicosanoid, einer Gallensäure und einem Androgen

30. Utilization of elbasvir/grazoprevir (EBR/GZR) and adoption of resistance associated substitutions (RAS) testing in real-world treatment of HCV genotype 1 (GT1) infection: results from the German Hepatitis C Registry (DHC-R)

31. Therapy with DAAs in patients with chronic hepatitis C and advanced chronic kidney disease: Real-world experience from the German Hepatitis C-Registry (DHC-R)

32. NS5A resistance patterns and treatment outcomes in DAA-naive genotype 1a chronic hepatitis C patients with and without baseline resistance-associated substitutions

35. EXPEDITION-I: efficacy and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus genotype 1, 2, 4, 5 or 6 infection and compensated cirrhosis

36. Impact of weight reduction on serum markers and liver histology including progression to cirrhosis in patients with nonalcoholic steatohepatitis (NASH) and bridging fibrosis

39. Spawning areas of eastern Baltic cod revisited : Using hydrodynamic modelling to reveal spawning habitat suitability, egg survival probability, and connectivity patterns

40. Connectivity of larval cod in the transition area between North Sea and Baltic Sea and potential implications for fisheries management

41. Slave to the rhythm: seasonal signals in otolith microchemistry reveal age of eastern Baltic cod (Gadus morhua)

46. Sicherheit und Wirksamkeit direkt antiviraler Substanzkombinationen zur Behandlung der chronischen Hepatitis- C -Virusinfektion bei älteren Patienten (> 70 Jahre): Ergebnisse aus dem Deutschen Hepatitis C-Register (DHC-R)

47. RAVs Datenbank: Untersuchung der Häufigkeit und Charakteristika von RAVs bei therapienaiven und DAA-erfahrenen Patienten

49. European Ravs Database: Frequency and Characteristics of Ravs in Treatment-Naïve and DAA-Experienced Patients

Catalog

Books, media, physical & digital resources